Cargando…

The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa – a systematic literature review

BACKGROUND: In the context of a move to universal health coverage, three separate systematic reviews were conducted to summarise available evidence on the direct costs of interventions for type 2 diabetes mellitus, hypertension, and cardiovascular disease in South Africa. METHODS: PubMed® and Web of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuku, Sithabiso D., Lekodeba, Nkgomeleng, Meyer-Rath, Gesine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743545/ https://www.ncbi.nlm.nih.gov/pubmed/36510178 http://dx.doi.org/10.1186/s12889-022-14730-4

Ejemplares similares

The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South Africa
por: Masuku, Sithabiso D., et al.
Publicado: (2023)

Integration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africa
por: Brennan, Alana T, et al.
Publicado: (2023)

The SENTINEL study of differentiated service delivery models for HIV treatment in Malawi, South Africa, and Zambia: research protocol for a prospective cohort study
por: Pascoe, Sophie, et al.
Publicado: (2023)

Integration of point-of-care screening for type 2 diabetes mellitus and hypertension with COVID-19 rapid antigen screening in Johannesburg, South Africa
por: Brennan, Alana T., et al.
Publicado: (2023)

Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System
por: Edoka, Ijeoma, et al.
Publicado: (2021)

The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case
por: Meyer-Rath, Gesine, et al.
Publicado: (2019)

Optimal HIV testing strategies for South Africa: a model-based evaluation of population-level impact and cost-effectiveness
por: Johnson, Leigh F., et al.
Publicado: (2019)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
por: Jo, Youngji, et al.
Publicado: (2021)

Costs and cost-effectiveness of treatment setting for children with wasting, oedema and growth failure/faltering: A systematic review
por: Mdege, Noreen Dadirai, et al.
Publicado: (2023)

The cost‐effectiveness of multi‐purpose HIV and pregnancy prevention technologies in South Africa
por: Quaife, Matthew, et al.
Publicado: (2018)

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
por: Schnippel, Kathryn, et al.
Publicado: (2012)

Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients
por: Nichols, Brooke E, et al.
Publicado: (2021)

The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost–Benefit Analysis
por: Meyer-Rath, Gesine, et al.
Publicado: (2015)

Cost-effectiveness of interventions to control cardiovascular diseases and diabetes mellitus in South Asia: a systematic review
por: Singh, Kavita, et al.
Publicado: (2018)

Cost of diabetes mellitus in Africa: a systematic review of existing literature
por: Mutyambizi, Chipo, et al.
Publicado: (2018)

Reduction in initiations of HIV treatment in South Africa during the COVID pandemic
por: Benade, Mariet, et al.
Publicado: (2022)

Role of data from cost and other economic analyses in healthcare decision-making for HIV, TB and sexual/reproductive health programmes in South Africa
por: Murphy, Joshua P, et al.
Publicado: (2021)

The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study
por: Erzse, Agnes, et al.
Publicado: (2019)

Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
por: Terris-Prestholt, Fern, et al.
Publicado: (2014)

The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis
por: Jamieson, Lise, et al.
Publicado: (2021)

The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
por: Matsimela, Katleho, et al.
Publicado: (2021)

Attrition through Multiple Stages of Pre-Treatment and ART HIV Care in South Africa
por: Fox, Matthew P., et al.
Publicado: (2014)

Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
por: Chiu, Calvin, et al.
Publicado: (2017)

Cost-effectiveness of interventions to control cardiovascular diseases and type 2 diabetes mellitus in South Asia: protocol for a systematic review
por: Singh, Kavita, et al.
Publicado: (2015)

Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study
por: Kranzer, Katharina, et al.
Publicado: (2012)

Prospects for HIV control in South Africa: a model-based analysis
por: Johnson, Leigh F., et al.
Publicado: (2016)

HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Factors influencing speech language pathologists’ and audiologists’ decision to pursue postgraduate studies in South Africa
por: Sebothoma, Ben, et al.
Publicado: (2021)

Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study
por: Campos, Nicole G., et al.
Publicado: (2018)

Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis
por: Jamieson, Lise, et al.
Publicado: (2022)

A review of the framework and strategy for disability and rehabilitation services in South Africa
por: Hussein El Kout, Naeema A.R., et al.
Publicado: (2022)

Costs of integrating HIV self-testing in public health facilities in Malawi, South Africa, Zambia and Zimbabwe
por: Sande, Linda Alinafe, et al.
Publicado: (2021)

Empowering Hypertensive Patients in South Africa to Improve Their Disease Management: A Pharmacist-Led Intervention
por: Rampamba, Enos M., et al.
Publicado: (2019)

Changing the South African national antiretroviral therapy guidelines: The role of cost modelling
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study
por: Bor, Jacob, et al.
Publicado: (2017)

Uncontrolled Hypertension and Its Determinants in Patients with Concomitant Type 2 Diabetes Mellitus (T2DM) in Rural South Africa
por: Adeniyi, Oladele Vincent, et al.
Publicado: (2016)

Prevalence of diabetes mellitus and hypertension amongst the HIV-positive population at a district hospital in eThekwini, South Africa
por: Rajagopaul, Althea, et al.
Publicado: (2021)

Secondary distribution of HIV self-test kits by HIV index and antenatal care clients: implementation and costing results from the STAR Initiative in South Africa
por: Zishiri, Vincent, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tma7ueod7hao3urio4509ertms